Skip to content
Back to announcement

Surat Pernyataan LK TW II.pdf

Financial statement Text extracted INAF

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 1

Page 1 OCR 0.912
SURAT PERNYATAAN DIREKSI

TENTANG TANGGUNG JAWAB ATAS
LAPORAN KEUANGAN

TANGGAL 30 JUNI 2026

DAN UNTUK PERIODE ENAM BULAN YANG
BERAKHIR PADA TANGGAL TERSEBUT

PT INDOFARMA (PERSERO) TBK
Kami yang bertanda tangan di bawah ini:

(/
indofarma

Member of Biofarma Group

DIRECTORS' STATEMENT LETTER

REGARDING THE RESPONSIBILITY FOR
THE FINANCIAL STATEMENTS

AS OF JUNE 30, 2026

AND FOR THE SIX-MONTH

PERIOD THEN ENDED

PT INDOFARMA (PERSERO) TBK

We, Ihe undersigned »

Nama Sahat Sihombing Name
Alamat Kantor Jl. Indofarma No. 1, Cikarang Barat 17530 Official Address
NIK 3175022310660002 ID Number
Jabatan Direktur Utama / President Director Position
Menyatakan bahwa : State that

l. Kami bertanggungjawab atas penyusunan dan penyajian — /. We are responsible for preparation and presentation of

laporan keuangan PT Indofarma Tbk,

2. Laporan keuangan PT Indofarma Tbk telah disusun dan
disajikan sesuai dengan Standar Akuntansi Keuangan di
Indonesia,

Semua informasi dalam laporan keuangan PT
Indofarma Tbk telah dimuat secara lengkap dan
benar,

b. Laporan keuangan PT Indofarma Tbk tidak
mengandung informasi atau fakta material yang
tidak benar, dan tidak menghilangkan informasi atau
fakta material,

4. Kami bertanggung jawab atas sistem pengendalian
internal dalam PT Indofarma Tbk.

Demikian pernyataan ini dibuat dengan sebenarnya.

the financial statements of PT Indofarma Tbk:

The financial statements of PT Indofarma Tbk have
been prepared and presented in accordance with
Indonesian Financial Accounting Standards:

a. All information contained in the financial
statements of PT Indofarma Tbk is complete and
correct,

b. The Jinancial statemenis of PT Indofarma Tbk do
not contain misleading material information or
Jacts, and do not omit material information and
Jacts,

We are responsible for the internal control system of PT
Indofarma Tbk.

This statement letter is made truthfilly.

Jakarta, 27 Juli 2026 / July 27, 2026
PT Indofarma Tbk

PT Indofarma Tbk
Jl Indofarma No.1, Cikarang Barat
Bekasi 17530 - Indonesia

Ph. 62-21-88323971/75
Fx. 62-21-88323972/73

Email: headoffice@indofarma.id
www.indofarma.id

File

File Open PDF
Source IDX
Size0.17 MB
Published28 Jul 2026
Pages1
Characters2,134
Text sourceOCR
OCR confidence0.912

Names mentioned 2 people and organisations named in the text · linked when the evidence is strong

linked person Sahat Sihombing p.1
possible org INDOFARMA (PERSERO) TBK p.1 ×28

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

Other files in this announcement 6

FinancialStatement-2026-II-INAF.xlsx done
inlineXBRL.zip done
↑↓ select ↵ open ⇧↵ see every result